Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Tracheal dexmedetomidine spray with or without ropivacaine for prevention of post-intubation hoarseness in major surgery
IRCT20190325043107N80Phase 3Completed
- Sponsor
- Tabriz University of Medical Sciences
- Start
- Mar 2025
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Small Molecules
- Countries
- 1
01
Overview
Phase 3 trial of dexmedetomidine and ropivacaine in dysphonia (2 arms), sponsored by Tabriz University of Medical Sciences. Started Mar 2025; status: completed.
02
Drugs
dexmedetomidineropivacaine
03
Conditions
dysphonia
Beyond the preview
Go deeper on IRCT20190325043107N80.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20190325043107N80.